Laura Korb Ferris, MD, PhD: New Data on Oral IL-23 Antagonist Peptide for Psoriasis
New phase 2b data from the FRONTIER 1 study showed promise for what could become the first and only oral IL-23 antagonist peptide for psoriasis.
Source: hcplive.com